These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25433941)

  • 21. Imatinib: muscle pain suggestive of a withdrawal syndrome.
    Prescrire Int; 2016 Mar; 25(169):70. PubMed ID: 27152402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cutaneous side effects of sorafenib and sunitinib].
    Autier J; Mateus C; Wechsler J; Spatz A; Robert C
    Ann Dermatol Venereol; 2008 Feb; 135(2):148-53; quiz 147, 154. PubMed ID: 18342102
    [No Abstract]   [Full Text] [Related]  

  • 23. Scrotal ulceration during induction therapy of acute promyelocytic leukemia with ATRA.
    Pavithran K; Arjun R; Aruna R; Thomas M
    Am J Hematol; 2004 Apr; 75(4):260-1. PubMed ID: 15054825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice.
    Agostino NM; Chinchilli VM; Lynch CJ; Koszyk-Szewczyk A; Gingrich R; Sivik J; Drabick JJ
    J Oncol Pharm Pract; 2011 Sep; 17(3):197-202. PubMed ID: 20685771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma.
    Arnaud L; Schartz NE; Bousquet G; Sarandi F; Verola O; Madelaine I; Kerob D; Lebbe C
    J Clin Oncol; 2008 Mar; 26(9):1569-71. PubMed ID: 18349416
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tretinoin and scrotal ulceration].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012; 139(8-9):588-9. PubMed ID: 22963972
    [No Abstract]   [Full Text] [Related]  

  • 27. Scrotal Ulceration and Pyrexia.
    Foley CC; Marren P
    JAMA Dermatol; 2017 Nov; 153(11):1181-1182. PubMed ID: 28724120
    [No Abstract]   [Full Text] [Related]  

  • 28. Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection.
    Lee NR; Jang JW; Kim HS; Yhim HY
    Korean J Intern Med; 2015 Jul; 30(4):550-3. PubMed ID: 26161025
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of acute haemolysis with 2 different multi target thyrosine kinase inhibitors in a patient with renal cancer.
    Berchem G; Dewilde S; Mahassen P
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):7-9. PubMed ID: 19514172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitors].
    Deslandres M; Sibaud V; Chevreau C; Delord JP
    Ann Dermatol Venereol; 2008 Jan; Spec No 1():16-24. PubMed ID: 18342113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RASopathic alopecia: hair changes associated with vemurafenib therapy.
    Piraccini BM; Patrizi A; Fanti PA; Starace M; Bruni F; Melotti B; Misciali C; Dika E
    J Am Acad Dermatol; 2015 Apr; 72(4):738-41. PubMed ID: 25773419
    [No Abstract]   [Full Text] [Related]  

  • 32. Should vascular effects of newer treatments be addressed more completely?
    Yang EH; Watson KE; Herrmann J
    Future Oncol; 2015; 11(14):1995-8. PubMed ID: 26198824
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia.
    Harding DJ; MacQuillan G; Howman R; de Boer B; Adams L; Mitchell A; Jeffrey G
    J Clin Oncol; 2016 Apr; 34(11):e97-8. PubMed ID: 25267743
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapeutic agents and the skin: An update.
    Heidary N; Naik H; Burgin S
    J Am Acad Dermatol; 2008 Apr; 58(4):545-70. PubMed ID: 18342708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Painful pustular eruption in the groin and the scrotum induced by erlotinib.
    Cholongitas E; Kokolakis GP; Ioannidou D
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):507-8. PubMed ID: 18363921
    [No Abstract]   [Full Text] [Related]  

  • 36. Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy.
    Tamura T; Tasaka T; Fujimoto M; Matsuhashi Y; Fukumot T; Mano S; Kuwajima M; Nagai M
    Haematologica; 2004 Sep; 89(9):ECR32. PubMed ID: 15377484
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe epistaxis with tyrosine kinase inhibitors.
    Hall PS; Kancherla K; Sastry PS; Brown JE
    Clin Oncol (R Coll Radiol); 2008 May; 20(4):318-9. PubMed ID: 18353621
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular toxicity of new agents.
    Maitland ML
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):657-9. PubMed ID: 18827788
    [No Abstract]   [Full Text] [Related]  

  • 39. Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect?
    Winn SK; Ellis S; Savage P; Sampson S; Marsh JE
    Nephrol Dial Transplant; 2009 Feb; 24(2):673-5. PubMed ID: 19039026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of hypothyroidism secondary to tyrosine kinase inhibitors: description of treatment in three distinct clinical settings].
    Pérez López G; Carrasco De La Fuente M; Menacho Román M; González Albarrán O; Cano Megías M
    Endocrinol Nutr; 2011 Feb; 58(2):94-6. PubMed ID: 21333617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.